As proven in in vitro and in animal models, mTOR-Is may decrease beta-cell mass through an increment of the rate of apoptosis (44–47), induce impairment of glucose-induced insulin secretion (45–49), and facilitate glucose intolerance and insulin resistance (50–52) (Table 1). The gene discussed is MTOR; the disease is Glucose intolerance.